These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23038197)

  • 1. [Immunosuppressive drugs and the development of skin cancer after organ transplantation].
    Gjersvik P; Helsing P; Holdaas H; Bergan S
    Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2064-8. PubMed ID: 23038197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
    Connolly K; Manders P; Earls P; Epstein RJ
    Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ transplantation and skin cancer: basic problems and new perspectives.
    Hofbauer GF; Bouwes Bavinck JN; Euvrard S
    Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Leblanc KG; Hughes MP; Sheehan DJ
    Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient.
    Signorell J; Hunziker T; Martinelli M; Koestner SC; Mohacsi PJ
    Transplant Proc; 2010 Nov; 42(9):3871-5. PubMed ID: 21094874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
    Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical insights for cancer outcomes in renal transplant patients.
    Alberú J
    Transplant Proc; 2010 Nov; 42(9 Suppl):S36-40. PubMed ID: 21095450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair.
    Kuschal C; Thoms KM; Schubert S; Schäfer A; Boeckmann L; Schön MP; Emmert S
    Exp Dermatol; 2012 Jan; 21(1):2-6. PubMed ID: 22151386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Great risk of skin cancer in patients with transplanted organs. Sun is the most dangerous enemy].
    Lindelöf B; Gäbel H
    Lakartidningen; 2000 Oct; 97(43):4822-4. PubMed ID: 11085025
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of non-melanoma skin cancer in solid organ transplant recipients.
    Specchio F; Saraceno R; Chimenti S; Nistico S
    Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous complications after organ transplantation].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3789-92. PubMed ID: 10574059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin cancer and other skin disorders in patients following solid organ transplantation].
    de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive drugs and the risk of cancer after organ transplantation.
    Dantal J; Soulillou JP
    N Engl J Med; 2005 Mar; 352(13):1371-3. PubMed ID: 15800234
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes.
    Schaper-Gerhardt K; Walter A; Schmitz-Rode C; Satzger I; Gutzmer R
    J Dermatol Sci; 2018 Nov; 92(2):172-180. PubMed ID: 30220530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
    Tessari G; Girolomoni G
    Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The historical link between solid-organ transplantation, immunosuppression, and skin cancer.
    Randle HW
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):595-7. PubMed ID: 15061841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma in solid-organ transplantation.
    Wu JJ; Orengo IF
    Dermatol Online J; 2002 Oct; 8(2):4. PubMed ID: 12546759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.